|Bid||37.75 x 900|
|Ask||44.63 x 1800|
|Day's Range||39.78 - 41.66|
|52 Week Range||39.78 - 90.92|
|Beta (5Y Monthly)||-0.08|
|PE Ratio (TTM)||74.22|
|Earnings Date||Nov 15, 2021 - Nov 19, 2021|
|Forward Dividend & Yield||0.24 (0.53%)|
|Ex-Dividend Date||Jul 23, 2021|
|1y Target Est||64.67|
LANCASTER, Calif., September 23, 2021--Simulations Plus announced a new grant award from the FDA to enhance the predictive power of the mechanistic TCAT model in its flagship GastroPlus.
With its stock down 20% over the past three months, it is easy to disregard Simulations Plus (NASDAQ:SLP). However...
LANCASTER, Calif., September 15, 2021--Simulations Plus releases ADMET Predictor 10.3 (APX.3) with key upgrades to its AIDD Module making it the premier program for AI-driven drug design.